CCG-232601

CCG-232601
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T26967-1mg 1 mg

7 - 10 business days*

373.00€
TGM-T26967-5mg 5 mg

7 - 10 business days*

1,640.00€
 
Description: CCG-232601 is a inhibitor of the Rho/MRTF/SRF transcriptional pathway. Target:... more
Product information "CCG-232601"
Description: CCG-232601 is a inhibitor of the Rho/MRTF/SRF transcriptional pathway. Target: Others. Smiles: C(=O)(C=1C=C(C=CC1)C=2C=CN=CC2)N3CC(C(NC4=CC=C(Cl)C=C4)=O)CC(F)(F)C3. References: Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma In Press, Corrected Proof, Available online 10 March 2017 Kim M. Hutchings, Erika M. Lisabeth, Walajapet Rajeswaran, Michael W. Wilson, Roderick J. Sorenson, Phillip L. Campbell, Jeffrey H. Ruth, Asif Amin, Pei-Suen Tsou, Jeffrey R. Leipprandt, Samuel R. Olson, Bo Wen, Ting Zhao, Duxin Sun, Dinesh Khanna, David A. Fox, Richard R. Neubig, Scott D. Larsen
Keywords: CCG232601, CCG 232601
Supplier: TargetMol
Supplier-Nr: T26967

Properties

MW: 455.88 D
Formula: C24H20ClF2N3O2

Database Information

CAS : 1922099-21-5| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CCG-232601"
Write a review
or to review a product.
Viewed